Efficacy of an oral contraceptive containing 0.030mg ethinylestradiol and 2mg dienogest (EE/DNG) for the treatment of acne – Comparison with placebo and with 0.035mg ethinylestradiol / 2mg cyproterone acetate (EE/CPA)
article
OA: closed
CC0
Abstract
Introduction: Papulopustular acne is a common skin disease characterized, beside other factors, by androgenic stimulation of sebaceous glands. Combined oral contraceptives (COC) containing progestins with anti-androgenic properties (including e.g. dienogest [DNG]) are therefore suitable for the treatment of acne. The aim of this study was to show the non-inferiority of EE/DNG compared to EE/CPA (a well-established hormonal anti-acne treatment), and the superiority of EE/DNG compared to placebo.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-05-13T18:03:57.834008+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK